JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, M. J.
Right arrow Articles by Chen, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, M. J.
Right arrow Articles by Chen, T. S.

Action of 5-thio-D-glucose on D-glucose metabolism: possible mechanism for diabetogenic effect

MJ Kelley and TS Chen

The effect of 5-thio-D-glucose (5-TG) on the hexosemonophosphate shunt (HMS) and on aerobic glycolysis was studied in the mouse small intestine. A time- and dose-dependent inhibition of 14CO2 production from D-[1-14C] or D-[6-14C]glucose was observed by 5-TG in vitro. Using everted rings of intestine, the HMS (measured by the C-1/C-6 ratio of 14CO2 produced) was inhibited approximately 60% relative to control by 11.0 mM 5-TG. The 14CO2 produced from D-[6-14C]glucose was not inhibited markedly until incubations were lengthened to 45 min or longer. The HMS in everted rings from mice treated with 5-TG at 50 mg/kg or 1.5 g/kg i.p. increased 200 or 130%, respectively, compared to saline-treated controls. In contrast, 14CO2 produced from D-[6- 14C]glucose was inhibited at both doses. Plasma D-glucose levels were measured 2 hr after treatment and were increased 100% at the low dose or 360% at the high dose, relative to controls (84.1 +/- 3.8 mg/100 ml). This study demonstrated that 5-TG inhibits D-glucose utilization in the mouse small intestine, which may contribute to the diabetogenic effect observed in vivo.

Volume 232, Issue 3, pp. 760-763, 03/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.